Consumers of lifestyle erectile dysfunction (ED) medications experienced price relief during the second half of 2019, according to eDrugstore\u2019s exclusive polling data from major pharmacy chains.<\/p>\n
The data eDrugstore collected came from 15 top retail pharmacy chains in the U.S. as well as three online medical facilitators, including eDrugstore.com.<\/p>\n
Prices for Viagra, Levitra, Cialis, and their generic equivalents sildenafil, vardenafil, and tadalafil fell during the summer of 2019 and then reached a plateau by the end of the year. Though the data eDrugstore will continue to collect in 2020 will tell the real story, the price plateau indicates that consumers may have seen most of the price benefit of new generic competitors for the time being.<\/p>\n
Viagra, however, will lose its remaining patent protection in the U.S. in April of 2020, and once that happens, new generic competitors could enter the market, prompting a new round of price cuts.<\/p>\n
Among the branded ED medications, Levitra prices dropped the most, with the cost of a 20-mg tablet of Levitra falling by 9.9% from July through December 2019. Prices for Viagra (100-mg tablet) and Cialis (20-mg tablet) each fell by around 3.2% during that same time period.<\/p>\n
The generic versions of these medications dropped even more significantly in price during the same period. Vardenafil, the generic version of Levitra, dropped by an astonishing 54.8%. Prices for both sildenafil (generic Viagra) and tadalafil (generic Cialis) fell by just over 27% during the second half of the year. These results are summarized in the following table.<\/p>\n
<\/p>\n
You can also visualize the monthly average price changes for the drugs in the following graph.<\/p>\n